Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer-Reference-Cited by-同舟云学术

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Published:2011-11 Issue:21 Volume:19 Page:6383-6399
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kaku Tomohiro,Hitaka Takenori,Ojida Akio,Matsunaga Nobuyuki,Adachi Mari,Tanaka Toshimasa,Hara Takahito,Yamaoka Masuo,Kusaka Masami,Okuda Teruaki,Asahi Satoru,Furuya Shuichi,Tasaka Akihiro

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference68 articles.

1. Carcinoma of the prostate;Kozlowski,1991

2. Physiologic Basis of Endocrine Therapy for Prostatic Cancer

3. Prostate Cancer

4. A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer

5. Overcoming Persistent Dependency on Androgen Signaling after Progression to Castration-Resistant Prostate Cancer: Fig. 1.

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors;Archiv der Pharmazie;2024-07-15

2. Role of heterocycles in inhibition of VEGFR-2 – a recent update (2019–2022);RSC Medicinal Chemistry;2024

3. Androgen receptor-dependent mechanisms mediating therapy resistance in prostate cancer;Therapy Resistance in Prostate Cancer;2024

4. Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment;Journal of Medicinal Chemistry;2023-05-16

5. Synthesis and functionalization of 6,7-dihydro-5H-pyrrolo[1,2-c]imidazole;Synthetic Communications;2023-03-14